Yes, there is a pill form of semaglutide, the same active ingredient in Ozempic. It’s called Rybelsus, and it’s made by the same company, Novo Nordisk. Rybelsus is currently FDA-approved for type 2 diabetes, not weight loss, which is an important distinction from how many people use Ozempic off-label.
What Rybelsus Is and How It Differs From Ozempic
Ozempic is a once-weekly injection. Rybelsus is a tablet you take by mouth once a day. Both deliver semaglutide, the compound that mimics a gut hormone called GLP-1 to lower blood sugar and reduce appetite. The core mechanism is identical.
Rybelsus is available in three strengths: 3 mg, 7 mg, and 14 mg. The 3 mg dose is a starter dose used for the first 30 days to ease your body into the medication. Most people move up to 7 mg or 14 mg for the therapeutic effect. By comparison, Ozempic’s maintenance doses are 0.5 mg, 1 mg, or 2 mg injected weekly. The numbers look very different because oral semaglutide requires a much higher dose to get enough of the drug absorbed through the stomach lining.
What the Pill Is Approved For
Rybelsus has two FDA-approved uses, both tied to type 2 diabetes. It’s approved to improve blood sugar control alongside diet and exercise, and to reduce the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes who are already at high risk. It is not currently approved for weight management in people without diabetes, which separates it from Wegovy, Novo Nordisk’s semaglutide injection specifically approved for obesity.
That said, some doctors do prescribe Rybelsus off-label for weight loss, just as Ozempic itself is frequently used off-label for that purpose.
How Well the Pill Works for Weight Loss
At the doses currently available (up to 14 mg), the oral version produces more modest weight loss than the higher injectable doses. But a higher-dose oral tablet, 50 mg, has been tested in clinical trials and shows results that rival the injections.
In the OASIS 1 trial, published in The Lancet, adults with overweight or obesity who took oral semaglutide 50 mg lost an average of 15.1% of their body weight over 68 weeks, compared to 2.4% with a placebo. That’s roughly the same ballpark as injectable semaglutide at its highest doses. In the same trial, 85% of people on the 50 mg pill lost at least 5% of their body weight, 69% lost at least 10%, and about one in three lost 20% or more. The 50 mg tablet is not yet available by prescription, but its development signals that a high-dose oral option for obesity could reach the market.
How You Take It
Rybelsus has stricter dosing instructions than most pills. You take it first thing in the morning on an empty stomach with no more than 4 ounces of plain water. Then you wait at least 30 minutes before eating, drinking anything else, or taking other oral medications. These rules exist because food and excess liquid interfere with absorption. The tablet uses a special absorption enhancer that only works properly in an empty stomach with minimal water.
This daily routine is a trade-off. Some people prefer it to a weekly injection; others find the fasting window inconvenient and prefer the simplicity of one shot per week that doesn’t come with meal-timing restrictions.
Side Effects
Because Rybelsus and Ozempic contain the same drug, their side effect profiles overlap significantly. The most common issues are gastrointestinal: nausea, diarrhea, vomiting, abdominal pain, constipation, and decreased appetite. These tend to be worst when you first start taking the medication or after a dose increase, and they usually improve over weeks as your body adjusts.
Most side effects are mild. The nausea that people commonly associate with semaglutide is the same whether you take the pill or the injection. There is no strong evidence that one form is dramatically better tolerated than the other at comparable therapeutic levels, though individual experiences vary.
Switching Between the Pill and the Injection
If you’re already on Ozempic and want to switch to Rybelsus (or vice versa), there’s a specific protocol. For someone discontinuing the 0.5 mg Ozempic injection, the FDA label recommends waiting one week and then starting Rybelsus at 7 mg or 14 mg daily. The transition isn’t one-to-one in terms of milligrams because the two forms are absorbed differently, so your doctor will determine the right starting dose based on where you are in treatment.
Cost and Availability
Rybelsus is available now at pharmacies with a prescription. Like Ozempic, it is a brand-name medication with no generic version yet, so cost can be significant without insurance coverage. Pricing varies, but both forms of semaglutide tend to fall in a similar range. Your insurance plan may cover one but not the other, or may require prior authorization for either, so it’s worth checking your formulary before assuming you can easily swap between them.